life scienc tool diagnost
ep ahead line item
mix lift organ revenu guid
ep ahead consensu crl ep
exceed estim weaker revenu rel line
profit factor line primarili drove beat
lower report revenu growth target vs prior
encouragingli higher organ growth bp higher prior
rang off-set fx rais ep guidanc
midpoint vs consensu reflect lower tax rate
chang oper margin target year ep
move reflect latest upsid target price
move higher view
organ revenu shi plan revenu increas
organ growth notabl plan
dsa rose organ estim rm
organ also plan despit continu china demand
also disappoint ebitda margin fell bp bp
plan flow million cash reserv stand
share may ebb share ytd vs view today
result may enough drive share higher lower
expect organ growth across busi line said rais
organ revenu growth guidanc hearten oper
margin target consist experi unchang
trade ep premium hist average contribut
neutral view risk demand shift biotech fund
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
charl river laboratori intern inc full servic earli
model research develop new drug devic
price jul rate neutral target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
blue sky scenario assum continu
robust industri trend expedit pronounc synergi
recent acquisit near term acceler larg pharma
biotech demand consist price increas identif
greater margin expans opportun continu market share
grey sky scenario assum oper
disrupt miscu recent acquisit weak
pressur increas insourc competit
 close
research model servic
discoveri safeti assess
research model servic
discoveri safeti assess
research model servic
discoveri safeti assess
research model servic
discoveri safeti assess
contribut acquisit
exclud acquisit fx week impact
contribut acquisit
exclud acquisit fx week impact
compani mention price
